PhenomeX Inc. (CELL) has a current stock price of $0.81. During the previous trading session, the stock witnessed a notable rise, reaching a high of $0.9249 after opening at $0.9134. The stock’s low for the day was $0.80, and it eventually closed at $0.87.
In terms of market performance, PhenomeX Inc. had a somewhat inconsistent run in. The highest value for the stock in the past year was $6.11 on 06/24/22, while the lowest value was $0.74 on 05/17/23.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
52-week price history of CELL Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. PhenomeX Inc.’s current trading price is -86.75% away from its 52-week high, while its distance from the 52-week low is 9.46%. The stock’s price range for this period has remained between $0.74 and $6.11. The Healthcare sector company’s shares managed to surpass a trading volume of around 0.67 million for the day, which was noticeably higher compared to the shares’ average daily volume of 0.63 million over the last three months.
Financial Performance and Market Capitalization
PhenomeX Inc. (CELL) has experienced a quarterly decline of -53.71% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 78.43M and boasts a workforce of 285 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.5416, with a change in price of -1.8600. Similarly, PhenomeX Inc. recorded 700,249 in trading volume during the last 100 days, posting a change of -69.66%.
CELL Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for CELL stands at 0.44. Similarly, the long-term debt-to-equity ratio is also 0.44.
CELL Stock Stochastic Average
As of today, the raw stochastic average of PhenomeX Inc. over the past 50 days is 10.29%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 15.22%. Additionally, the Stochastic %K and %D values for the company were 21.75% and 20.87%, respectively, over the past 20 days.
CELL Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. The index has shown a price loss of -69.78% this year. Over the last six months, there has been a stronger performance of -72.35%. The price of CELL leaped by -30.17% during the last 30 days period. For the last 5-days stocks have improved 2.87%.
